AI assistant
Sending…
LISATA THERAPEUTICS, INC. — Director's Dealing 2013
Aug 20, 2013
34931_dirs_2013-08-20_7391e59e-9667-466c-9cc2-d5f73168b5e7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2013-08-19
Reporting Person: Dickey Robert IV (Chief Financial Officer)
More from LISATA THERAPEUTICS, INC.
Merger & Acquisition
2026
Jun 1
Regulatory Filings
2026
Jun 1
Merger & Acquisition
2026
May 29
Regulatory Filings
2026
May 29
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 4
Regulatory Filings
2026
May 4
Annual Report
2026
Apr 28
Regulatory Filings
2026
Apr 15
Regulatory Filings
2026
Apr 15